Bial | 123,716 followers on LinkedIn. Bial is a family-owned company with a rich history of over 100 years, dedicated to patient welfare, with products available in more than 50 countries. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), Bial has established an ambitious R&D programme. The key focus areas for the Group are neurosciences and rare diseases.